» Articles » PMID: 36501135

The Role of Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone in Irritable Bowel Syndrome: A Bidirectional Two-Sample Mendelian Randomization Study

Overview
Journal Nutrients
Date 2022 Dec 11
PMID 36501135
Authors
Affiliations
Soon will be listed here.
Abstract

Several observational studies have indicated the potential associations among calcium, vitamin D (Vit-D), and irritable bowel syndrome (IBS). However, the causal relationship deduced from these studies is subject to residual confounding factors and reverse causation. Therefore, we aimed to explore the bidirectional causal effects among serum calcium, Vit-D, PTH, and IBS at the genetic level by a two-sample Mendelian randomization (MR) analysis of the datasets from IEU OpenGWAS database. Sensitivity analyses were performed to evaluate the robustness. The estimates were presented as odds ratios (ORs) with their 95% confidence intervals (CIs). The results of the inverse variance weighted method did not reveal any causal relationship between the genetically predisposed calcium (OR = 0.92, 95% CI: 0.80-1.06, = 0.25) and Vit-D (OR = 0.99, 95% CI: 0.83-1.19, = 0.94) level and the risk of IBS. The bidirectional analysis demonstrated that genetic predisposition to IBS was associated with a decreased level of PTH (beta: -0.19, 95%CI: -0.34 to -0.04, = 0.01). In conclusion, the present study indicates no causal relationship between the serum calcium and Vit-D concentrations and the risk of IBS. The potential mechanisms via which IBS affects serum PTH need to be further investigated.

Citing Articles

Identification of genetic association between mitochondrial dysfunction and knee osteoarthritis through integrating multi-omics: a summary data-based Mendelian randomization study.

Xie J, Ma R, Xu X, Yang M, Yu H, Wan X Clin Rheumatol. 2024; 43(11):3487-3496.

PMID: 39259428 PMC: 11489259. DOI: 10.1007/s10067-024-07136-7.


Causal relationship between gut microbiota and idiopathic pulmonary fibrosis: A two-sample Mendelian randomization.

Fan S, Xue B, Ma J Medicine (Baltimore). 2024; 103(29):e39013.

PMID: 39029004 PMC: 11398756. DOI: 10.1097/MD.0000000000039013.


New Insights on the Therapeutic Potential of Runt-Related Transcription Factor 2 for Osteoarthritis: Evidence from Mendelian Randomization.

Xie J, Xu X, Yang M, Yu H, Hao J, Yang D Rheumatol Ther. 2024; 11(4):1001-1009.

PMID: 38874858 PMC: 11264677. DOI: 10.1007/s40744-024-00682-1.

References
1.
Abuelazm M, Muhammad S, Gamal M, Labieb F, Amin M, Abdelazeem B . The Effect of Vitamin D Supplementation on the Severity of Symptoms and the Quality of Life in Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2022; 14(13). PMC: 9268238. DOI: 10.3390/nu14132618. View

2.
Bek S, Teo Y, Tan X, Fan K, Siah K . Association between irritable bowel syndrome and micronutrients: A systematic review. J Gastroenterol Hepatol. 2022; 37(8):1485-1497. DOI: 10.1111/jgh.15891. View

3.
Palmer T, Lawlor D, Harbord R, Sheehan N, Tobias J, Timpson N . Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2011; 21(3):223-42. PMC: 3917707. DOI: 10.1177/0962280210394459. View

4.
Talley N, Powell N, Walker M, Jones M, Ronkainen J, Forsberg A . Role of smoking in functional dyspepsia and irritable bowel syndrome: three random population-based studies. Aliment Pharmacol Ther. 2021; 54(1):32-42. DOI: 10.1111/apt.16372. View

5.
Creed F . Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies. Aliment Pharmacol Ther. 2019; 50(5):507-516. DOI: 10.1111/apt.15396. View